Flexion Reports Positive Topline Results from Phase 2a Trial with FX006
June 17, 2014 at 16:11 PM EDT
Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced positive topline clinical trial results from a Phase 2a synovial fluid PK ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.